Publications by authors named "Yu Futami"

Claim this Profile
S
Serum vesicle biomarkers reflect the disease activity of idiopathic pulmonary fibrosis.
Yuya Shirai, Takatoshi Enomoto, Yoshito Takeda, Ryuya Edahiro, Miho Takahashi-Itoh, Yu Futami, Shinji Futami

J Transl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis.
Takatoshi Enomoto, Yuya Shirai, Yoshito Takeda, Ryuya Edahiro, Shigeyuki Shichino, Yu Futami, Shinji Futami

JCI Insight· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer.
Takashi Hirai, Yujiro Naito, Shohei Koyama, Yoshimitsu Nakanishi, Kentaro Masuhiro, Yu Futami

JCI Insight· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles.
Yu Futami, Yoshito Takeda, Taro Koba, Ryohei Narumi, Yosui Nojima, Shinji Futami

Int Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leucine-rich a-2 glycoprotein as a potential biomarker of idiopathic multicentric Castleman disease with pulmonary involvement: a single-center case-control study from Japan.
So Takata, Yoshito Takeda, Haruhiko Hirata, Yuya Shirai, Takayoshi Morita, Yu Futami

J Thorac Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-33 Induces Sema4A Expression in Dendritic Cells and Exerts Antitumor Immunity.
Yasuhiko Suga, Izumi Nagatomo, Yuhei Kinehara, Shohei Koyama, Daisuke Okuzaki, Yu Futami

J Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres.
Taro Koba, Yoshito Takeda, Ryohei Narumi, Takashi Shiromizu, Yosui Nojima, Yu Futami

ERJ Open Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis.
Takeshi Tsuda, Masayuki Nishide, Yohei Maeda, Yoshitomo Hayama, Shohei Koyama, Yu Futami

J Allergy Clin Immunol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.
Akio Osa, Takeshi Uenami, Shohei Koyama, Kosuke Fujimoto, Daisuke Okuzaki, Yu Futami

JCI Insight· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis